Ironwood Pharmaceuticals, Inc. ( NASDAQ:IRWD – Get Rating ) CEO Thomas A. Mccourt sold 21,148 shares of Ironwood Pharmaceuticals stock in a transaction dated Monday, May 8th. The stock was sold at an average price of $10.62, for a total value of $224,591.76. Following the completion of the transaction, the chief executive officer now directly owns 820,916 shares in the company, valued at approximately $8,718,127.92. The sale was disclosed in a document filed with the SEC, which is available at this link .

https://www.dailypolitical.com/2023/05/10/insider-selling-ironwood-pharmaceuticals-inc-nasdaqirwd-ceo-sells-21148-shares-of-stock.html

#dailypolitical